Showing results (271-280 of 328) with videos related to

Sort By:
Pageof 33
Leukemia|February 17, 2006
Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemiaU Platzbecker, C Thiede, M Füssel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2013
Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)L Stenholm, J Stoehlmacher-Williams, S E Al-Batran, et al.
Bone Marrow Transplantation|September 22, 2015
Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 yearsG Andreola, M Labopin, D Beelen, et al.
Bone Marrow Transplantation|January 13, 2004
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysisJ Schetelig, M Bornhäuser, M Kiehl, et al.
World Journal of Gastroenterology|January 31, 2002
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study)S Miehlke, C Kirsch, B Dragosics, et al.
Annals of Hematology|March 22, 2002
Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphomaM Hänel, N Kröger, S Sonnenberg, et al.
Leukemia|November 20, 2015
Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemiaJ Balss, C Thiede, T Bochtler, et al.
Leukemia|August 21, 2013
Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting systemC Arndt, A Feldmann, M von Bonin, et al.
Cytometry|August 10, 2000
Shift of aberrant antigen expression at relapse or at treatment failure in acute leukemiaU Oelschlägel, R Nowak, A Schaub, et al.
Leukemia|December 8, 2010
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trialF Stölzel, M Pfirrmann, W E Aulitzky, et al.
Pageof 33